ReviewCancers2020
Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors?
Nagio Takigawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it
ReviewCancers2020
Nagio Takigawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.